factual

Achaogen bankruptcy after plazomicin approval

Achaogen spent years and millions developing the antibiotic plazomicin, which the FDA approved in June 2018 only for urinary tract infections rather than the bloodstream infections the company had bet on; the company filed for bankruptcy nine months later, illustrating why startups now avoid antibiotic development.

factualpending

Speaker

Matt McCarthy

Evidence Quote

“the company filed for bankruptcy nine months later”

Source

166 - The Plague Years— Making Sense with Sam Harris
Created: 6/14/2026, 2:12:29 AM

Your notes

Loading notes...